Chemoradiation with and without adjuvant extrafascial hysterectomy for IB2 cervical carcinoma
Author:
Publisher
BMJ
Subject
Obstetrics and Gynaecology,Oncology
Reference21 articles.
1. Analysis of central recurrent disease in stages I and II squamous cell carcinomas of the cervix on intact uterus;Durrance;Am J Roentgenol Radium Ther Nucl Med,1969
2. Clinical studies with adjunctive surgery and irradiation therapy in the treatment of carcinoma of the cervix;Rutledge;Cancer,1976
3. Combined radiation therapy and extra-fascial hysterectomy in the treatment of stage IB barrel-shaped cervical cancer;Gallion;Cancer,1985
4. Stage IB or IIA-B carcinoma of the intact uterine cervix greater than or equal to 6 cm in diameter: is adjuvant extrafascial hysterectomy beneficial?;Mendenhall;Int J Radiat Oncol Biol Phys,1991
5. The influence of tumor size and morphology on the outcome of patients with FIGO stage IB squamous cell carcinoma of the uterine cervix;Eifel;Int J Radiat Oncol Biol Phys,1994
Cited by 23 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Locally Advanced Cervical Cancer: Neoadjuvant Treatment versus Standard Radio-Chemotherapy—An Updated Meta-Analysis;Cancers;2024-07-15
2. Why Is Surgery Still Done after Concurrent Chemoradiotherapy in Locally Advanced Cervical Cancer in Romania?;Cancers;2024-01-19
3. The Association of Preoperative PET-CT and Survival in Patients with Resectable Cervical Cancer;Journal of Clinical Medicine;2022-12-01
4. Debulking hysterectomy followed by chemoradiotherapy versus chemoradiotherapy for FIGO stage (2019) IB3/II cervical cancer;Cochrane Database of Systematic Reviews;2022-09-16
5. ATOMICC trial: a randomized, open-label, phase II trial of anti-PD1, dostarlimab, as maintenance therapy for patients with high-risk locally advanced cervical cancer after chemoradiation;International Journal of Gynecologic Cancer;2022-04-20
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3